Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


August M&A Analysis: Slow Month Highlighted By Unique Technologies

Executive Summary

The dog-days of summer produced just a handful of mergers and acquisitions in the medtech sector and no blockbuster deals. However, several companies made smaller deals for innovative products in a range of sectors including IVDs, cardiovascular devices, and ophthalmology.


Related Content

Myriad's GeneSight Psychotropic Genetic Test Improves Depression Therapy In Trial
Zimmer Biomet Adds CD Diagnostics To List Of 2016 Acquisitions
M&A Analysis: Slow Month Highlighted By A Few Big Deals
Myriad To Enter Neuroscience Market With $225m Assurex Acquisition
IPO Update: Intellia Launch Shows CRISPR Still Excites While Others Struggle
Myriad's myChoice To Be Used In More Cancer Clinical Trials
Medtronic scores sixth M&A deal, while SNN gains and Philips sheds
Arthrex to purchase struggling Cardo’s joint arthroplasty division


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts